Todd Shryock

CONMED says it is shifting focus from gastroenterology to core surgical innovations to enhance growth and profitability while winding down key distribution agreements.

ViaLase launching a trial for incision-free glaucoma treatment, aiming to redefine IOP management with innovative, safer solutions.

Todd's background in scaling advanced robotic platforms, building global engineering teams, and driving innovation in endoscopy and minimally invasive surgery will support Swan’s push to commercialize a flexible endoluminal surgical robotics platform.

Being successful with in-office rapid testing requires a careful look at your patient population, staffing, and workflows

Blood-based diagnostic aims to reduce unnecessary prostate biopsies and improve cancer risk assessment.

Switching to value-based care also means changing how you code and how you approach patient care

New federal loan limits in the OBBBA threaten to increase medical school debt and worsen physician shortages, impacting diversity in health care.

GE Healthcare launches Pristina Recon DL, a new AI-driven mammography technology enhancing image quality and supporting early breast cancer detection.

The growing trend toward device-based metabolic interventions

Effort will prioritize technologies with strong clinical and commercial potential.

Transmural Systems launches TELLTALE, an innovative electrosurgical guidewire, enhancing safety in transcatheter aortic valve replacement procedures.

The growing trend toward device-based metabolic interventions

Deal is expected to accelerate innovation in cancer diagnostics and expand access to early detection tools at a time when global cancer rates continue to climb

GE HealthCare expects the deal to be completed early next year and immediately contribute to its bottomline.

Mindray's TE Air e5M ultrasound machine advances imaging with wireless technology, offering affordability, portability, and features for diverse clinical settings.

The growing trend toward device-based metabolic interventions

Dexcom Smart Basal optimizes insulin dosing for Type 2 diabetes, integrating CGM data for personalized recommendations and enhancing patient care efficiency.

Does it matter what technology tools a health care employer has?

TriSalus unveils the TriNav XP Infusion System, enhancing drug delivery for solid tumors with advanced embolic particle capabilities and improved navigation.

BrainsWay's FDA-approved Deep TMS system offers new hope for adolescents with depression, enhancing access to effective noninvasive treatment options.

The growing trend toward device-based metabolic interventions

FDA 510(k) clearance for its Hemastyl gel device marks the first technology that has treated the tissue surrounding chronic wounds and prevented numerous amputations.

Orpyx's digital foot-monitoring platform for diabetic foot ulcer prevention will be tested in a NIH-funded trial, aiming to reduce amputation risks.

The growing trend toward device-based metabolic interventions

Hubly Surgical's FDA-cleared auto-stop drill enhances spinal surgery safety, preventing injury with innovative technology for precise, efficient procedures.

Augmedics unveiled the X2 augmented reality surgical headset, which enhances precision and comfort in spinal surgeries with advanced imaging and ergonomic design.

ZAP Surgical's new Axon system advances brain radiosurgery with FDA and CE approvals, enhancing precision and efficiency in treatment planning.

The growing trend toward device-based metabolic interventions